← Back to headlines
Eli Lilly Embarks on $20 Billion Acquisition Spree
Eli Lilly is reportedly undertaking a $20 billion buying spree as the pharmaceutical giant seeks to define its next strategic phase.
27 May, 13:37 — 27 May, 13:37
Sources
Showing 1 of 1 sources
